Multicenter in vitro evaluation of SM-7338, a new carbapenem.

A new carbapenem, SM-7338, was compared with imipenem, cefotaxime, and ceftazidime at five medical centers. Nearly 6,000 strains were tested by reference methods of the National Committee for Clinical Laboratory Standards, and SM-7338 inhibited the largest percentage of gram-negative bacilli. Its sp...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jones, R N, Aldridge, K E, Allen, S D, Barry, A L, Fuchs, P C, Gerlach, E H, Pfaller, M A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1989
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC172479/
https://ncbi.nlm.nih.gov/pubmed/2658796
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak